Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from DEA

Hunter Biden Trial: Prosecution To Rest Case After Two Witnesses

Stay updated on the Hunter Biden trial in Wilmington, Delaware with key testimonies and decisions shaping the case.

Matthew Perry’s death investigation: Here’s what we know

Los Angeles police, US Drug Enforcement Administration, and US Postal Inspection Service looking for who supplied Friends star with ketamine

The Independent UK · May 22, 2024

Investigation Underway Into Source Of Fatal Ketamine Dose For Actor

Investigation launched into actor Matthew Perry's death due to ketamine overdose. Fans mourn the loss.

Criminal Investigation Launched For Matthew Perry Tragedy, Homicide Detectives Involved

LAPD investigates Matthew Perry's ketamine dosage half a year after his death. The post Criminal Investigation Launched For Matthew Perry Tragedy, Homicide Detectives Involved first appeared on Bored Panda.

Bored Panda · May 22, 2024

Matthew Perry's Death Investigation Involves DEA And USPS

Learn about the ongoing investigation into the ketamine-related death of actor Matthew Perry and the collaborative efforts of law enforcement agencies to u...

The Evidence Suggests the DEA Still Has Not Come Around on Rescheduling Marijuana

It looks like Attorney General Merrick Garland overrode the agency's recalcitrant drug warriors in deciding to reclassify the drug.

Reason · May 21, 2024

Matthew Perry: Los Angeles police investigating into actor’s death

LAPD and DEA working on joint criminal inquiry into how Friends star, who died of acute effects of ketamine, got the prescription drug

The Guardian - US · May 21, 2024

Read news from The Economist, FT, and more,
with one subscription

1 Growth Stock Under $10 to Buy and Hold

Amidst the DEA's anticipated rescheduling of marijuana, Curaleaf Holdings emerges as a compelling growth stock under $10, buoyed by strategic expansions, regulatory tailwinds, and bullish analyst forecasts in the flourishing cannabis industry.

Barchart · May 21, 2024

Death of an Authoritarian

Plus: The editors field a question from a Gen Z libertarian.

Reason · May 20, 2024

Top U.S. drug agency a notable holdout in Biden's push to loosen federal marijuana restrictions

The Biden administration’s push to reclassify marijuana as a less-dangerous drug is going forward without the support of the nation’s premier narcotics agency

The Independent UK · May 20, 2024

Biden's Spin on Marijuana's Rescheduling Exaggerates Its Practical Impact

Contrary to the president's rhetoric, moving marijuana to Schedule III will leave federal pot prohibition essentially unchanged.

Reason · May 17, 2024

DEA Moves To Reclassify Marijuana as a Schedule III Drug

For over 50 years, marijuana has been in the same category of controlled substances as heroin and LSD. The DEA is finally proposing to end that ludicrous policy.

Reason · May 16, 2024

Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift

The Justice Department has formally moved to reclassify marijuana as a less dangerous drug in a historic shift in generations of U.S. drug policy

The Independent UK · May 16, 2024

More than 100,000 people in the US died of drug overdoses in 2023

Sobering figure obscures the fact that the number of overdose deaths in the US declined for the first time since 2018

The Guardian - US · May 15, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU · May 15, 2024

U.S. drug deaths declined slightly in 2023 but remained at crisis levels

Powerful synthetic opioids and drugs like meth and cocaine still flood U.S. communities, fueling historically high overdose deaths.

Barchart · May 6, 2024

Up 100% YTD, Is Canopy Growth Stock Overbought?

Canopy Growth stock has surged over 100% in 2024. Despite its recent gains, CGC stock remains a high-risk bet, due to its weak fundamentals and negative profit margins.

Reason · May 6, 2024

Biden Exaggerates His Work To Reform Marijuana Policy

Biden has not delivered on his promise to decriminalize marijuana.

WEKU · May 3, 2024

Scientists welcome new rules on marijuana, but research will still face obstacles

When marijuana becomes a Schedule III instead of a Schedule I substance under federal rules, researchers will face fewer barriers to studying it. But there will still be some roadblocks for science.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason · May 1, 2024

Rescheduling Marijuana Does Not Address Today's Central Cannabis Issue

Moving marijuana to Schedule III, as the DEA plans to do, leaves federal pot prohibition essentially untouched.

Kiplinger · May 1, 2024

How the Biden Marijuana Shift Could Impact Taxes

A pending Biden administration marijuana rule change could help some businesses lower their taxes.

DEA Proposes Rescheduling Marijuana To Less Dangerous Drug

The U.S. DEA considers reclassifying marijuana to Schedule III, impacting research and business operations.

Reason · Apr 30, 2024

DEA Finally Expected To Reclassify Marijuana

The change from Schedule I to Schedule III is welcome, but removing it from the schedules altogether is the best option.

International Business Times · Apr 30, 2024

Biden Administration Eyes Major Shift In Marijuana Policy, Reports Say

This reclassification would signal a recognition of the drug's potential medical benefits and its comparatively lower risk of abuse compared to other substances.

Florida Man Charged In Record Drug Seizure

Florida man charged with possession of large quantities of meth, cocaine, fentanyl, and counterfeit pills, along with firearms in Orlando. DEA agents execu...

Reason · Apr 23, 2024

It Took Me Months To Get the ADHD Meds the DEA Says Are Overprescribed

I'm the DEA's poster child for prescription stimulant abuse: a 30-something adult who needs a telehealth psychiatrist and can't remember what day the garbage truck comes.

1 … 23 24 25 26

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Health and Human Services

the US Postal Service

77 stories

Drug Enforcement Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.